Chargement en cours...
Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy
Non-Hodgkin lymphoma (NHL) presents as both localized and disseminated disease with spread to secondary sites carrying a worse prognosis. Although pathways driving NHL dissemination have been identified, there are few therapies capable of inhibiting them. Here, we report a novel role for the immunom...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3208297/ https://ncbi.nlm.nih.gov/pubmed/21828138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-02-338020 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|